Reversal of in vitro drug induced myeloid suppression by lithium

A. M. Miller; A. A. Yunis

Reversal of in vitro drug induced myeloid suppression by lithium

A. M. Miller, A. A. Yunis

Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

We have investigated the ability of lithium to protect against chloramphenicol (CAP) and chlorpromazine (CPZ) induced suppression of human myeloid colony forming cells (CFU(C)). In the standard semi-solid agar assay for human CFU(C) lithium (0.5-10 x 10^-3 M) enhances myeloid colony formation by 30-40% and protects against CAP and CPZ induced suppression, in a manner similar to increasing CSF concentrations. Prior depletion of adherent cell populations from human marrow eliminates the lithium effects, thus suggesting a primary action through CSF production.

Original language	English (US)
Pages (from-to)	775-780
Number of pages	6
Journal	Experimental Hematology
Volume	9
Issue number	7
State	Published - 1981

ASJC Scopus subject areas

Molecular Biology
Hematology
Genetics
Cell Biology
Cancer Research

Cite this

@article{c09023cad1ff4b9194c3403aa8e29521,

title = "Reversal of in vitro drug induced myeloid suppression by lithium",

abstract = "We have investigated the ability of lithium to protect against chloramphenicol (CAP) and chlorpromazine (CPZ) induced suppression of human myeloid colony forming cells (CFU(C)). In the standard semi-solid agar assay for human CFU(C) lithium (0.5-10 x 10-3 M) enhances myeloid colony formation by 30-40% and protects against CAP and CPZ induced suppression, in a manner similar to increasing CSF concentrations. Prior depletion of adherent cell populations from human marrow eliminates the lithium effects, thus suggesting a primary action through CSF production.",

author = "Miller, {A. M.} and Yunis, {A. A.}",

year = "1981",

language = "English (US)",

volume = "9",

pages = "775--780",

journal = "Experimental Hematology",

issn = "0301-472X",

publisher = "Elsevier Inc.",

number = "7",

}

TY - JOUR

T1 - Reversal of in vitro drug induced myeloid suppression by lithium

AU - Miller, A. M.

AU - Yunis, A. A.

PY - 1981

Y1 - 1981

N2 - We have investigated the ability of lithium to protect against chloramphenicol (CAP) and chlorpromazine (CPZ) induced suppression of human myeloid colony forming cells (CFU(C)). In the standard semi-solid agar assay for human CFU(C) lithium (0.5-10 x 10-3 M) enhances myeloid colony formation by 30-40% and protects against CAP and CPZ induced suppression, in a manner similar to increasing CSF concentrations. Prior depletion of adherent cell populations from human marrow eliminates the lithium effects, thus suggesting a primary action through CSF production.

AB - We have investigated the ability of lithium to protect against chloramphenicol (CAP) and chlorpromazine (CPZ) induced suppression of human myeloid colony forming cells (CFU(C)). In the standard semi-solid agar assay for human CFU(C) lithium (0.5-10 x 10-3 M) enhances myeloid colony formation by 30-40% and protects against CAP and CPZ induced suppression, in a manner similar to increasing CSF concentrations. Prior depletion of adherent cell populations from human marrow eliminates the lithium effects, thus suggesting a primary action through CSF production.

UR - http://www.scopus.com/inward/record.url?scp=0019490715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019490715&partnerID=8YFLogxK

M3 - Article

C2 - 7318979

AN - SCOPUS:0019490715

VL - 9

SP - 775

EP - 780

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 7

ER -

Reversal of in vitro drug induced myeloid suppression by lithium

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this